These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 34533265)

  • 21. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
    Dursun R; Temiz SA
    Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of high-dose acyclovir in pityriasis rosea.
    Drago F; Vecchio F; Rebora A
    J Am Acad Dermatol; 2006 Jan; 54(1):82-5. PubMed ID: 16384760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic features of pityriasis rosea-like drug eruption secondary to imatinib: A case report and review of the literature.
    Durgin JS; Whittington CP; Harrell J; Mervak JE; Smith EH
    J Cutan Pathol; 2024 Nov; 51(11):860-865. PubMed ID: 39021288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pityriasis Rosea: A Comprehensive Classification.
    Drago F; Ciccarese G; Rebora A; Broccolo F; Parodi A
    Dermatology; 2016; 232(4):431-7. PubMed ID: 27096928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
    Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
    J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of human herpes virus 6 and 7 in the pathogenesis of pityriasis rosea.
    Yildirim M; Aridogan BC; Baysal V; Inaloz HS
    Int J Clin Pract; 2004 Feb; 58(2):119-21. PubMed ID: 15055857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl.
    Engelmann I; Ogiez J; Ogiez L; Alidjinou EK; Lazrek M; Dewilde A; Hober D
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29674359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.
    Alame MM; Chamsy DJ; Zaraket H
    Br J Clin Pharmacol; 2018 May; 84(5):1077-1080. PubMed ID: 29520857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pityriasis Rosea Induced by COVID-19 Vaccination.
    Khattab E; Christaki E; Pitsios C
    Eur J Case Rep Intern Med; 2022; 9(2):003164. PubMed ID: 35265550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
    Cyrenne BM; Al-Mohammedi F; DeKoven JG; Alhusayen R
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e546-e548. PubMed ID: 33982814
    [No Abstract]   [Full Text] [Related]  

  • 31. Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.
    Carballido Vázquez AM; Morgado B
    Br J Dermatol; 2021 Aug; 185(2):e34. PubMed ID: 33904157
    [No Abstract]   [Full Text] [Related]  

  • 32. Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia.
    Bangash HK; Finch T; Petronic-Rosic V; Sethi A; Abramsohn E; Lindau ST
    J Low Genit Tract Dis; 2013 Apr; 17(2):226-9. PubMed ID: 23343697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmar herald patch in pityriasis rosea.
    Polat M; Yildirim Y; Makara A
    Australas J Dermatol; 2012 Aug; 53(3):e64-5. PubMed ID: 22881477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pityriasis rosea in a hepatitis B-positive patient treated with pegylated interferon α2a: report of a case and review of the literature.
    Drago F; Javor S; Bruzzone L; Drago F; Parodi A; Picciotto A
    Dermatology; 2014; 228(1):10-3. PubMed ID: 24335203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pityriasis Rosea: Diagnosis and Treatment.
    Villalon-Gomez JM
    Am Fam Physician; 2018 Jan; 97(1):38-44. PubMed ID: 29365241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical presentations of pityriasis rosea: case presentations.
    Chuh A; Zawar V; Lee A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):120-6. PubMed ID: 15649208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
    Shin SH; Hong JK; Hong SA; Li K; Yoo KH
    Int J Infect Dis; 2022 Jan; 114():88-89. PubMed ID: 34740803
    [No Abstract]   [Full Text] [Related]  

  • 38. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.
    Brazzelli V; Prestinari F; Roveda E; Barbagallo T; Bellani E; Vassallo C; Orlandi E; Passamonti F; Borroni G
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S240-3. PubMed ID: 16227099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center.
    Atzori L; Pinna AL; Ferreli C; Aste N
    Dermatol Online J; 2006 Jan; 12(1):1. PubMed ID: 16638369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent pityriasis rosea: A case report.
    Li A; Li P; Li Y; Li W
    Hum Vaccin Immunother; 2018 Apr; 14(4):1024-1026. PubMed ID: 29182459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.